Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 3 stocks made the list for top value stocks in the Medical Equipment, Supplies & Distribution industry. Those looking for value stocks to add to their portfolio may want to use this list as a starting point for further investment research.
Why Focus on Undervalued Medical Equipment, Supplies & Distribution Stocks?
Value investors seek to buy stocks at a discount to their intrinsic value. Long-term returns show that such strategies are advantageous. Value stocks, as a group, tend to outperform growth stocks over extended periods of time. Typically, value investors perform financial analysis of numerous metrics, don’t follow the herd and are long-term investors.
AAII’s A+ Investor Value Grade is derived from a stock’s Value Score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.
What Goes Into AAII’s Value Grade?
Stock evaluation requires access to huge amounts of data as well as the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movement. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors with that task.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for more than just value. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. Some stocks may even have null values for certain metrics like the price-earnings ratio or the price-to-book ratio but not others. An example of this would be a company with losses instead of profits or a negative book value because of heavy borrowing. Negative earnings or book value result in non-meaningful ratios that are left blank or null.
Click the button below to learn more about A+ Investor and subscribe today.
3 Undervalued Medical Equipment, Supplies & Distribution Stocks
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Medical Equipment, Supplies & Distribution industry for Thursday, September 05, 2024. Let’s take a closer look at their individual scores to see how they measure up against each other and the Medical Equipment, Supplies & Distribution industry median.
| Company | Ticker | Price/Sales | Price/Earnings | EV/EBITDA | Shareholder Yield | Price/Book Value | Price/Free Cash Flow | Value Grade |
| Embecta Corp | EMBC | 0.85 | 13.6 | 7.8 | 2.8% | na | na | B |
| Owens & Minor, Inc. | OMI | 0.12 | na | 4.9 | (1.2%) | 1.42 | 8.5 | A |
| Tactile Systems Technology Inc | TCMD | 1.13 | 9.7 | 8.2 | (2.2%) | 1.58 | 9.3 | B |
The Value Grade is assigned based on how each stock’s composite valuation compares to all other stocks.
The process for assigning grades starts with each variable for a given stock. The percentile rankings for all valid ratios that a stock has are calculated. So, for instance, a stock could have a price-to-book ranking in the 43rd percentile, a price-earnings ranking in the 67th percentile, a price-to-sales ranking in the 23rd percentile, etc. Then, those rankings are averaged for each stock. (A minimum of two valid variables are required, though all six will be used if available.)
Once the average of the individual variables is calculated, that average is ranked against all stocks. Put another way, each stock’s composite valuation is compared to all other stocks. These ranks are then sorted into quintiles from the cheapest 20% (a grade of A) to the most expensive 20% (a grade of F).
As always, we recommend that you conduct proper due diligence and research before investing in any security. We also suggest that investors utilize numerous grades, not just value, when it comes to deciding whether a company is a good fit for their allocation needs.
Embecta Corp’s Value Grade
Value Grade:
| Metric | Score | EMBC | Industry Median |
| Price/Sales | 30 | 0.85 | 2.86 |
| Price/Earnings | 35 | 13.6 | 40.2 |
| EV/EBITDA | 35 | 7.8 | 14.5 |
| Shareholder Yield | 27 | 2.8% | (2.1%) |
| Price/Book Value | na | na | 2.58 |
| Price/Free Cash Flow | na | na | 32.5 |
Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It has clearance from the FDA for its proprietary disposable insulin delivery system, which is indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D).
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Embecta Corp has a Value Score of 80, which is considered to be undervalued.
When you look at Embecta Corp’s price-to-sales ratio at 0.85 compared to the industry median at 2.86, this company has a lower price relative to revenue compared to its peers. This could make Embecta Corp’s stock more attractive for value investors.
Embecta Corp’s price-earnings ratio is 13.63 compared to the industry median at 40.18. This means it has a lower share price relative to earnings compared to its peers. This could make Embecta Corp more attractive for value investors.
Now, let’s assess Embecta Corp’s EV/EBITDA ratio, also known as enterprise multiple. At 7.8, when compared to the industry median of 14.5, the company may be considered undervalued in relation to its peers. Value investors could use the enterprise multiple to identify stocks that are considered overvalued or undervalued relative to their industry.
Shareholder yield is the sum of a stock’s dividend yield (paid over previous 12 months minus special dividends) and the percentage of net share buybacks over the previous 12 months. Embecta Corp’s shareholder yield is higher than its industry median ratio of (2.10%). Value investors may look for an attractive shareholder yield because it can be a powerful tool for identifying if the company has a good management team.
Owens & Minor, Inc.’s Value Grade
Value Grade:
| Metric | Score | OMI | Industry Median |
| Price/Sales | 5 | 0.12 | 2.86 |
| Price/Earnings | na | na | 40.2 |
| EV/EBITDA | 15 | 4.9 | 14.5 |
| Shareholder Yield | 59 | (1.2%) | (2.1%) |
| Price/Book Value | 44 | 1.42 | 2.58 |
| Price/Free Cash Flow | 21 | 8.5 | 32.5 |
Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own proprietary products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. It also offers a variety of programs providing outsourced logistics and marketing solutions to its suppliers as well. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and a provider of integrated home healthcare equipment and related services.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Owens & Minor, Inc. has a Value Score of 85, which is considered to be undervalued.
Owens & Minor, Inc.’s price-to-book ratio is higher than its peers. This could make Owens & Minor, Inc. less attractive for value investors when compared to the industry median at 2.58.
You can read more about Owens & Minor, Inc.’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Tactile Systems Technology Inc’s Value Grade
Value Grade:
| Metric | Score | TCMD | Industry Median |
| Price/Sales | 38 | 1.13 | 2.86 |
| Price/Earnings | 20 | 9.7 | 40.2 |
| EV/EBITDA | 37 | 8.2 | 14.5 |
| Shareholder Yield | 65 | (2.2%) | (2.1%) |
| Price/Book Value | 48 | 1.58 | 2.58 |
| Price/Free Cash Flow | 23 | 9.3 | 32.5 |
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Tactile Systems Technology Inc has a Value Score of 67, which is considered to be undervalued.
Tactile Systems Technology Inc’s price-earnings ratio is 9.7 compared to the industry median at 40.2. This means that it has a lower price relative to its earnings compared to its peers. This makes Tactile Systems Technology Inc more attractive for value investors.
Tactile Systems Technology Inc’s price-to-book ratio is higher than its peers. This could make Tactile Systems Technology Inc less attractive for value investors when compared to the industry median at 2.58.
You can read more about Tactile Systems Technology Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Other Medical Equipment, Supplies & Distribution Stock Grades
Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate revisions and quality—on the A+ Stock Grades Screener.
Also, if you want full access to all of AAII’s premium services, you can subscribe to one convenient bundled plan called AAII Platinum where you can try out A+ Investor, AAII Dividend Investing, the Stock Superstars Report, Growth Investing and VMQ Stocks. With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Medical Equipment, Supplies & Distribution stocks as well as other industrys.
Choosing Which of the 3 Best Medical Equipment, Supplies & Distribution Stocks Is Right for You
Choosing which value stocks to invest in will ultimately depend on your individual goals and allocation; however, comparing similar value stocks in the same industry can help you analyze which might be better investments for you in the long run. So, let’s take a look at the Value Grade for all of our stocks.
- Embecta Corp stock has a Value Grade of B.
- Owens & Minor, Inc. stock has a Value Grade of A.
- Tactile Systems Technology Inc stock has a Value Grade of B.
Now that you have a bit more background about each of the 3 undervalued stocks in the Medical Equipment, Supplies & Distribution industry as well as their overall grades, it’s time for you to conduct additional research to see if these could fit your portfolio needs based on your goals and risk tolerance. AAII can help you figure out both and identify which investments align with what works best for you.
We do so through a program of education that teaches you to invest for yourself and become an effective manager of your own wealth—no more relying on others for your financial independence. You can rely on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis that makes you a better investor.
A+ Investor adds to that qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
Additional Resources About Medical Equipment, Supplies & Distribution Stocks
Want to learn more about Medical Equipment, Supplies & Distribution stocks to see if they could be the right investment for you? Check out some additional resources and articles to help you on your financial journey.
- 3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Thursday, September 05
- Why Inspire Medical Systems Inc’s (INSP) Stock Is Up 11.26%
- Why Myriad Genetics, Inc.’s (MYGN) Stock Is Down 7.65%
- Why Nevro Corp’s (NVRO) Stock Is Down 4.32%
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
at only 6.9%
Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.